ES2035668T3 - Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma. - Google Patents

Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.

Info

Publication number
ES2035668T3
ES2035668T3 ES199090104423T ES90104423T ES2035668T3 ES 2035668 T3 ES2035668 T3 ES 2035668T3 ES 199090104423 T ES199090104423 T ES 199090104423T ES 90104423 T ES90104423 T ES 90104423T ES 2035668 T3 ES2035668 T3 ES 2035668T3
Authority
ES
Spain
Prior art keywords
asthma
treatment
molecules
intercellular
union links
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES199090104423T
Other languages
English (en)
Spanish (es)
Inventor
Craig D. Wegner
Robert H. Gundel
Robert Rothlein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharmaceuticals Inc
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc filed Critical Boehringer Ingelheim Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2035668T3 publication Critical patent/ES2035668T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C07K14/70553—Integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2845—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ES199090104423T 1989-03-09 1990-03-08 Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma. Expired - Lifetime ES2035668T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US32123789A 1989-03-09 1989-03-09
US32123989A 1989-03-09 1989-03-09
US32101889A 1989-03-09 1989-03-09
US32448189A 1989-03-16 1989-03-16
US40140989A 1989-09-01 1989-09-01

Publications (1)

Publication Number Publication Date
ES2035668T3 true ES2035668T3 (es) 1993-04-16

Family

ID=27541038

Family Applications (1)

Application Number Title Priority Date Filing Date
ES199090104423T Expired - Lifetime ES2035668T3 (es) 1989-03-09 1990-03-08 Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.

Country Status (13)

Country Link
EP (1) EP0387701B1 (enExample)
JP (1) JP3119483B2 (enExample)
KR (1) KR0177519B1 (enExample)
AT (1) ATE79270T1 (enExample)
AU (1) AU638450B2 (enExample)
CA (1) CA2047721C (enExample)
DE (1) DE69000248T2 (enExample)
DK (1) DK0387701T3 (enExample)
ES (1) ES2035668T3 (enExample)
GR (1) GR3006073T3 (enExample)
HU (1) HU216313B (enExample)
NZ (1) NZ232868A (enExample)
WO (1) WO1990010453A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
DE68929096T2 (de) 1988-09-01 2000-05-11 Bayer Corp., Pittsburgh Menschliches Rhinovirusrezeptorprotein, das die Virusinfektionsanfälligkeit hemmt
US5776775A (en) * 1989-02-21 1998-07-07 Dana-Farber Cancer Institute Anti-LAM 1-3 antibody and hybridoma
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
EP0468257B1 (en) * 1990-07-20 1999-09-01 Bayer Corporation Multimeric form of human rhinovirus receptor protein
US5674982A (en) * 1990-07-20 1997-10-07 Bayer Corporation Multimeric form of human rhinovirus receptor protein
AU8765391A (en) * 1990-10-03 1992-04-28 Boehringer Ingelheim Pharmaceuticals, Inc. Method for treating inflammation using anti-idiotypic antibodies
CA2056143A1 (en) * 1990-11-28 1992-05-29 Michael S. Diamond The mac-1 binding site of icam-1
ES2094837T3 (es) * 1991-04-03 1997-02-01 Boehringer Ingelheim Pharma Metodo para inhibir la toxicidad pulmonar por oxigeno.
GB9115364D0 (en) * 1991-07-16 1991-08-28 Wellcome Found Antibody
JPH06502195A (ja) * 1991-07-31 1994-03-10 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 内皮性白血球粘着分子−１およびそれに対する抗体の喘息治療における使用
JPH07502727A (ja) * 1991-10-01 1995-03-23 ザ・ジエネラル・ホスピタル・コーポレーシヨン 接着分子に対する抗体を用いた同種移植片拒絶の防止
US5871734A (en) * 1992-01-13 1999-02-16 Biogen, Inc. Treatment for asthma with VLA-4 blocking agents
US5708141A (en) * 1992-05-11 1998-01-13 Corvas International, Inc. Neutrophil inhibitors
RU94046450A (ru) * 1992-06-22 1996-10-10 Майлз Инк. (US) Мультимерная icam-i, способ усиления связывания icam-i с лигандом, фармацевтическая композиция, способ индукции декансидации, способ необратимого ингибирования заражения клеток
US6391452B1 (en) 1997-07-18 2002-05-21 Bayer Corporation Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
US20030035798A1 (en) 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
CA2454358A1 (en) 2001-07-19 2003-07-31 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
GB0525214D0 (en) 2005-12-12 2006-01-18 Bioinvent Int Ab Biological materials and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080044T3 (es) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular y sus ligandos de fijacion.
ATE114972T1 (de) * 1987-11-02 1994-12-15 Baylor College Medicine Verwendung von icam-1 oder ihre funktionelle derivate zur behandlung unspezifischer entzündungen.
CA1341055C (en) * 1987-12-08 2000-07-18 Alan Mcclelland Transfectant cell lines which express the major human rhinovirus receptor

Also Published As

Publication number Publication date
WO1990010453A1 (en) 1990-09-20
EP0387701A1 (en) 1990-09-19
DK0387701T3 (da) 1992-12-07
HU216313B (hu) 1999-06-28
KR920700667A (ko) 1992-08-10
NZ232868A (en) 1995-05-26
JP3119483B2 (ja) 2000-12-18
ATE79270T1 (de) 1992-08-15
HU902883D0 (en) 1991-12-30
CA2047721C (en) 2004-01-06
CA2047721A1 (en) 1990-09-10
AU638450B2 (en) 1993-07-01
AU5349990A (en) 1990-10-09
EP0387701B1 (en) 1992-08-12
DE69000248D1 (de) 1992-09-17
JPH04504127A (ja) 1992-07-23
GR3006073T3 (enExample) 1993-06-21
DE69000248T2 (de) 1993-01-07
KR0177519B1 (ko) 1999-03-20
HUT65843A (en) 1994-07-28

Similar Documents

Publication Publication Date Title
ES2035668T3 (es) Uso de moleculas de adherencia intercelular y sus ligandos de union en el tratamiento del asma.
DE3852909D1 (de) Lineare Kette von Parallelprozessoren und Benutzungsverfahren davon.
DE69130445D1 (de) Die Mac-1-Bindungsstelle von ICAM-1
DK0745852T3 (da) Anvendelse af funktionelle derivater af intercellulær adhæsion-molekylet ICAM-1 i antiviral terapi
ATE238047T1 (de) Verwendung von n,n-bis (phenylcarbamoylmethyl) dimethylammoniumchlorid und derivaten davon zur behandlung von chronischem schmerz
DE3876688D1 (de) Thixothrope anstrichmittelzusammensetzung und gegenstaende damit.
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
DK336688D0 (da) Nucleosider od fremgangsmaade til fremstilling deraf
ES2043609T3 (es) Composiciones de interleucina-2.
DE59004875D1 (de) Falzapparat zum Herstellen von längs- und/oder quergefalzten Produkten.
GR1001151B (el) Νεα xρηση θειορεδοξινης
ATE147746T1 (de) Derivate von fluorphosphonat-nukleotiden
ATE311399T1 (de) 2'-deoxy-4'-thioribonucleoside als antivirale und antikrebsmittel
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE3576689D1 (de) Oxa- und thiadiazolylderivate und ihre verwendung.
ATE56873T1 (de) Verwendung von hygromycin und epihygromycin zur behandlung von dysentrie bei schweinen.
TR26931A (tr) Lak koagülasyonunda molipten bilesiklerinin kullanilmasi.
DE3767175D1 (de) Therapeutische zusammenstellungen auf basis von 3-alkoxyflavonen und derivate von 3-alkoxyflavonen.
ES2072869T3 (es) Uso de derivados de la 1,4-dihidropiridina en el tratamiento del alcoholismo.
ATE165594T1 (de) Triarylethylenderivate zur therapeutischen verwendung
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
DK74889A (da) Alkanoyl- og aroyloxazoloner
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
DE69418050D1 (de) Antivirale analoge von difluorostaton
ES2004489A4 (es) Gametocidas de piridina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 387701

Country of ref document: ES